Literature DB >> 25761925

Update on juvenile systemic sclerosis.

Ivan Foeldvari1.   

Abstract

Juvenile systemic sclerosis is an orphan disease of the macro- and microvasculature with an unknown etiology. Although pediatric and adult classification systems have been developed, neither has been validated yet. Recent publications have shown a shift in the subset pattern in juvenile-onset adult patients, with a better outcome in these patients as compared with young adult patients. As a first step in assessing activity, damage, and severity, a pediatric severity score--a modification of the adult Medsger scale--was proposed but has not been validated. An activity score also has been developed but has not yet been published. Currently, treatment approaches are based only on adult data, and problems exist in extrapolating these data to a pediatric population.

Entities:  

Mesh:

Year:  2015        PMID: 25761925     DOI: 10.1007/s11926-014-0491-y

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  39 in total

1.  Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database.

Authors:  Ivan Foeldvari; Alan Tyndall; Francesco Zulian; Ulf Müller-Ladner; László Czirjak; Chris Denton; Ottilia Kowal-Bielecka; Dominique Farge Bancel; Marco Matucci-Cerinic
Journal:  Rheumatology (Oxford)       Date:  2012-06-22       Impact factor: 7.580

2.  T lymphocyte abnormalities in juvenile systemic sclerosis patients.

Authors:  Andreas Reiff; Kenneth I Weinberg; Timothy Triche; Bernadette Masinsin; Kris M Mahadeo; Chuan-Hao Lin; Diane Brown; Robertson Parkman
Journal:  Clin Immunol       Date:  2013-08-07       Impact factor: 3.969

Review 3.  Review: evidence that systemic sclerosis is a vascular disease.

Authors:  Marco Matucci-Cerinic; Bashar Kahaleh; Fredrick M Wigley
Journal:  Arthritis Rheum       Date:  2013-08

4.  Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey.

Authors:  I Foeldvari; M Zhavania; N Birdi; R J Cuttica; S H de Oliveira; P B Dent; R Elborgh; F Falcini; G Ganser; H Girschick; R Häfner; R Joos; W Kuis; P Pelkonen; A M Prieur; K Rostropowicz-Denisiewicz; R Russo; A Savolainen; A Siamopoulou-Mayridou; F Zulian
Journal:  Rheumatology (Oxford)       Date:  2000-05       Impact factor: 7.580

5.  Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.

Authors:  Kyle M Walker; Janet Pope
Journal:  Semin Arthritis Rheum       Date:  2012-03-29       Impact factor: 5.532

6.  A disease severity scale for systemic sclerosis: development and testing.

Authors:  T A Medsger; A J Silman; V D Steen; C M Black; A Akesson; P A Bacon; C A Harris; S Jablonska; M I Jayson; S A Jimenez; T Krieg; E C Leroy; P J Maddison; M L Russell; R K Schachter; F A Wollheim; H Zacharaie
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

7.  The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.

Authors:  Francesco Zulian; Patricia Woo; Balu H Athreya; Ronald M Laxer; Thomas A Medsger; Thomas J A Lehman; Marco Matucci Cerinic; Giorgia Martini; Angelo Ravelli; Ricardo Russo; Ruben Cuttica; Sheila Knupp Feitosa de Oliveira; Christopher P Denton; Franco Cozzi; Ivan Foeldvari; Nicolino Ruperto
Journal:  Arthritis Rheum       Date:  2007-03-15

8.  EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Authors:  O Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2009-01-15       Impact factor: 19.103

Review 9.  Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations.

Authors:  Johannes P Schwaiger; Dinesh Khanna; J Gerry Coghlan
Journal:  Eur Respir Rev       Date:  2013-12

10.  Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.

Authors:  Tünde Minier; Serena Guiducci; Silvia Bellando-Randone; Cosimo Bruni; Gemma Lepri; László Czirják; Oliver Distler; Ulrich A Walker; Jaap Fransen; Yannick Allanore; Christopher Denton; Maurizio Cutolo; Alan Tyndall; Ulf Müller-Ladner; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2013-08-12       Impact factor: 19.103

View more
  5 in total

1.  New Insights into Cardiac Involvement in Juvenile Scleroderma: A Three-Dimensional Echocardiographic Assessment Unveils Subclinical Ventricle Dysfunction.

Authors:  Reyhan Dedeoglu; Amra Adroviç; Funda Oztunç; Sezgin Sahin; Kenan Barut; Ozgur Kasapcopur
Journal:  Pediatr Cardiol       Date:  2017-09-14       Impact factor: 1.655

2.  French recommendations for the management of systemic sclerosis.

Authors:  Eric Hachulla; Christian Agard; Yannick Allanore; Jerome Avouac; Brigitte Bader-Meunier; Alexandre Belot; Alice Berezne; Anne-Sophie Bouthors; Geraldine Condette-Wojtasik; Joël Constans; Pascal De Groote; Elisabeth Diot; Florence Dumas; Patrick Jego; Francisca Joly; David Launay; Veronique Le Guern; Janine-Sophie Le Quintrec; Geraldine Lescaille; Christophe Meune; Bruno Moulin; Christelle Nguyen; Nadine Omeish; Frederic Pene; Marie-Aleth Richard; Juliette Rochefort; Alexandra Roren; Olivier Sitbon; Vincent Sobanski; Marie-Elise Truchetet; Luc Mouthon
Journal:  Orphanet J Rare Dis       Date:  2021-07-26       Impact factor: 4.123

3.  Clinical and laboratory profile of juvenile-onset systemic sclerosis in a Brazilian cohort.

Authors:  Percival D Sampaio-Barros; Adriana B Bortoluzzo; Ana Paula T Del Rio; Ana Paula Luppino-Assad; Danieli Co Andrade; João Francisco Marques-Neto
Journal:  J Scleroderma Relat Disord       Date:  2018-04-24

4.  The frequency of pulmonary hypertension in patients with juvenile scleroderma.

Authors:  Amra Adrovic; Funda Oztunc; Kenan Barut; Aida Koka; Refet Gojak; Sezgin Sahin; Tuncalp Demir; Ozgur Kasapcopur
Journal:  Bosn J Basic Med Sci       Date:  2015-08-22       Impact factor: 3.363

5.  Juvenile Scleroderma: A Referral Center Experience.

Authors:  Amra Adrovic; Sezgin Şahin; Kenan Barut; Özgür Kasapçopur
Journal:  Arch Rheumatol       Date:  2018-01-18       Impact factor: 1.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.